Tokyo, Dec. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059954) titled 'Study on the Diagnostic Utility of the CD56/CD3 Ratio in Gastrointestinal Mucosal Lymphocytes for GVHD after Hematopoietic Stem Cell Transplantation' on Dec. 3.
Study Type:
Observational
Primary Sponsor:
Institute - Okayama University Hospital
Condition:
Condition - Patients after hematopoietic stem cell transplantation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify whether the CD56/CD3 ratio of gastrointestinal mucosal lymphocytes is useful for diagnosing gastrointestinal GVHD in patients after hematopoietic stem cell transplantation
Basic objectives2 ...